Mindray shakes up top ranks; Urological devices predicted to boom;

 @FierceMedDev: After another quarterly slide, Wright Medical is planning to reorganize. Report | Follow @FierceMedDev

 @MarkHFierce: FDA warns the maker of a light therapy product designed to treat fungal meningitis that the product is unapproved. More | Follow @MarkHFierce

 @DamianFierce: Myriad Genetics is raising its full-year guidance after a strong quarter. More | Follow @DamianFierce

> China's Mindray Medical ($MR) has shuffled its top ranks as co-CEO Xu Hang has resigned, leaving Li Xiting the sole head of the company. News

> Looking to finance its upcoming mitosis, Abbott Laboratories' ($ABT) AbbVie spinoff raised $14.7 billion in the largest dollar-denominated debt issue ever. After the January split, devices and diagnostics will remain under the Abbott moniker, while drug development will fall to the newfangled AbbVie. Story

> The global market for urology devices is poised to explode, according to analysts, predicted to reach $8.6 billion by 2022. Article

> Becton Dickinson ($BDX) has named William Kozy as its new chief operating officer, a position he will fill in addition to his current job as executive vice president. More

> American Medical Systems is recalling some of its AdVance slings in Europe, warning that the sutures they contain may not last as long as labeled. Item

> Medtronic ($MDT) has donated $250,000 to the Red Cross to support victims of Hurricane Sandy. Release

Biotech News

 @FierceBiotech: From FierceVaccines.com: PsiOxus lands $2.7M for ovarian cancer vaccine trial. Item | Follow @FierceBiotech

 @JohnCFierce: Buyout Buzz: The most frequently cited takeover targets in biotech. Special Report | Follow @JohnCFierce

 @RyanMFierce: Crowdsourcing kick spurs interest in NIH drug recycling. More | Follow @RyanMFierce

> PCSK9 rivals Amgen and Pfizer angle for AHA spotlight with promising data. Story

> Takeda snaps up CNS drug developer Envoy Therapeutics in $140M deal. News

> Ambit Biosciences finds $50M more from VCs as leukemia therapy advances. Article

Pharma News

@FiercePharma: Congressional hearings on the meningitis debacle to begin next week. FDA's Hamburg on the sked: Report | Follow @FiercePharma

> Teva shunts Americas chief aside in management shuffle. Article

> Bristol-Myers to slash 480 sales-related jobs in NJ. Story

Biotech Research News

> Failed AstraZeneca drugs gain second chance with $11M U.K. program. News

> UC Davis team finds new lung cancer Rx target. Article

> 'Abdominal imaging window' lets researchers crack cancer metastasis secrets. Story

> Scientists wield stem cells to undo male infertility inflicted by cancer treatment in monkeys. More

Pharma Manufacturing News

> Sigma-Aldrich gets foothold in S. Korea with API deal. Article

> German Bayer partners with Russian drug manufacturer. News

> India's price-setting agency prepares for plant inspections. Story

Suggested Articles

The agency also gave the company’s diagnostic, run on the high-throughput Panther Fusion laboratory platform, a green light for pooled testing.

Smith & Nephew has signed up to acquire Integra LifeSciences’ orthopedics business focused on the growing upper and lower extremity markets.

The company describes the continuous glucose monitor as the world’s smallest and thinnest diabetes sensor, with a disc about the size of two pennies.